跳至主要内容
临床试验/JPRN-UMIN000027988
JPRN-UMIN000027988已完成未知

Analysis of liver cancer development in patients who showed sustained viral response to chronic hepatitis C virus infection by receiving direct acting-antiviral therapy, a prospective multicenter study - A prospective multicenter study on hepatocarcinogenesis after DAA-induced SVR for HCV

Kurume University0 个研究点目标入组 3,011 人开始时间: 2017年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
3,011

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 99years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) (Potentially) pregnant woman and lactating woman 2) Allergic reaction for DAAs and biological agents including vaccines 3) Difficult-to-control heart diseases 4) Severe liver injury, including Child-Pugh class B and C 5) Contraindicated drugs for combination with DAAs 6) Uncontrolled diabetes mellitus 7) Inappropriate patients who are judged by study-managing doctors

研究者

相似试验